Cargando…

Regulatory Testing for Endocrine Disruptors; Need for Validated Methods and Integrated Approaches

Detalles Bibliográficos
Autores principales:	Grignard, Elise, de Jesus, Kelly, Hubert, Philippe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Toxicology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8915824/ https://www.ncbi.nlm.nih.gov/pubmed/35295107 http://dx.doi.org/10.3389/ftox.2021.821736

Ejemplares similares

Development of new approach methods for the identification and characterization of endocrine metabolic disruptors—a PARC project
por: Braeuning, Albert, et al.
Publicado: (2023)

Immune and Nervous Systems Interaction in Endocrine Disruptors Toxicity: The Case of Atrazine
por: Galbiati, Valentina, et al.
Publicado: (2021)

Failure to Launch: The Endocrine Disruptor Screening Program at the U.S. Environmental Protection Agency
por: Maffini, Maricel V., et al.
Publicado: (2022)

Endocrine Disruptors in a New Era of Predictive Toxicology and Dealing With the “More is Different” Challenge
por: Svingen, Terje
Publicado: (2022)

Transcriptional profiling of the developing rat ovary following intrauterine exposure to the endocrine disruptors diethylstilbestrol and ketoconazole
por: Kugathas, Indusha, et al.
Publicado: (2023)

Calretinin is a novel candidate marker for adverse ovarian effects of early life exposure to mixtures of endocrine disruptors in the rat
por: Johansson, Hanna Katarina Lilith, et al.
Publicado: (2020)

Evidenced-Based Approaches to Support the Development of Endocrine-Mediated Adverse Outcome Pathways: Challenges and Opportunities
por: Audouze, Karine, et al.
Publicado: (2021)

Regulatory needs and activities to address the retinoid system in the context of endocrine disruption: The European viewpoint
por: Grignard, Elise, et al.
Publicado: (2020)

Endocrine Disruptors: Improving Regulatory Science Policy
por: Ricci, Paolo F.
Publicado: (2015)

Brazil’s Regulatory Context for Using New Approach Methodologies (NAMs) on the Registration of Products
por: Villela, Izabel Vianna, et al.
Publicado: (2022)

Editorial: Endocrine-Disrupting Compounds in Plastics and Their Effects on Reproduction, Fertility, and Development
por: Maradonna, Francesca, et al.
Publicado: (2022)

Standardisation of defined approaches for skin sensitisation testing to support regulatory use and international adoption: position of the International Cooperation on Alternative Test Methods
por: Casati, S., et al.
Publicado: (2017)

Bovine In Vitro Oocyte Maturation and Embryo Production Used as a Model for Testing Endocrine Disrupting Chemicals Eliciting Female Reproductive Toxicity With Diethylstilbestrol as a Showcase Compound
por: Asimaki, K., et al.
Publicado: (2022)

Developmental Exposure to Endocrine Disrupting Chemicals and Its Impact on Cardio-Metabolic-Renal Health
por: Singh, Radha Dutt, et al.
Publicado: (2021)

Azole Fungicides and Their Endocrine Disrupting Properties: Perspectives on Sex Hormone-Dependent Reproductive Development
por: Draskau, Monica Kam, et al.
Publicado: (2022)

The alamar blue assay in the context of safety testing of nanomaterials
por: Longhin, Eleonora Marta, et al.
Publicado: (2022)

Novel machine learning models to predict endocrine disruption activity for high-throughput chemical screening
por: Collins, Sean P., et al.
Publicado: (2022)

Roadbumps at the Crossroads of Integrating Behavioral and In Vitro Approaches for Neurotoxicity Assessment
por: Harry, G. Jean, et al.
Publicado: (2022)

Use of new approach methodologies (NAMs) to meet regulatory requirements for the assessment of tobacco and other nicotine-containing products
por: Miller-Holt, Jacqueline, et al.
Publicado: (2022)

How to facilitate the implementation of 3D models in China by applying good in vitro method practice for regulatory use
por: Liu, Yanfeng, et al.
Publicado: (2023)

Do macrophages play a role in the adverse effects of endocrine disrupting chemicals (EDCs) on testicular functions?
por: Cui, Haoyi, et al.
Publicado: (2023)

Editorial: Chemical testing using new approach methodologies (NAMs)
por: Stucki, Andreas O., et al.
Publicado: (2022)

Endocrine disruptors also function as nervous disruptors and can be renamed endocrine and nervous disruptors (ENDs)
por: Seralini, Gilles-Eric, et al.
Publicado: (2021)

Use of new approach methodologies (NAMs) to meet regulatory requirements for the assessment of industrial chemicals and pesticides for effects on human health
por: Stucki, Andreas O., et al.
Publicado: (2022)

The colony forming efficiency assay for toxicity testing of nanomaterials—Modifications for higher-throughput
por: Rundén-Pran, Elise, et al.
Publicado: (2022)

Editorial: Women in regulatory toxicology: 2021
por: Ågerstrand, Marlene, et al.
Publicado: (2022)

Revision of ICH S8 Needed?
por: Van Der Laan, Jan Willem
Publicado: (2022)

Endocrine Disruptors and Obesity
por: Darbre, Philippa D.
Publicado: (2017)

Innovative tools and methods for toxicity testing within PARC work package 5 on hazard assessment
por: De Castelbajac, Thalia, et al.
Publicado: (2023)

The Impact of Endocrine Disruptors on Endocrine Targets
por: Gregoraszczuk, Ewa L., et al.
Publicado: (2013)

Concurrent Evaluation of Mortality and Behavioral Responses: A Fast and Efficient Testing Approach for High-Throughput Chemical Hazard Identification
por: Thunga, Preethi, et al.
Publicado: (2021)

Prioritization of chemicals in food for risk assessment by integrating exposure estimates and new approach methodologies: A next generation risk assessment case study
por: Luijten, Mirjam, et al.
Publicado: (2022)

Integrated Genotoxicity Testing of three anti-infective drugs using the TGx-DDI transcriptomic biomarker and high-throughput CometChip(®) assay in TK6 cells
por: Buick, Julie K., et al.
Publicado: (2022)

New approach methods to improve human health risk assessment of thyroid hormone system disruption–a PARC project
por: Ramhøj, Louise, et al.
Publicado: (2023)

Guidance for the identification of endocrine disruptors in the context of Regulations (EU) No 528/2012 and (EC) No 1107/2009
por: Andersson, Niklas, et al.
Publicado: (2018)

Canadian Regulatory Perspective on Next Generation Risk Assessments for Pest Control Products and Industrial Chemicals
por: Bhuller, Yadvinder, et al.
Publicado: (2021)

Endocrine disruptors : effects on male and female reproductive systems /
Publicado: (2005)

A Case Study on Integrating a New Key Event Into an Existing Adverse Outcome Pathway on Oxidative DNA Damage: Challenges and Approaches in a Data-Rich Area
por: Huliganga, Elizabeth, et al.
Publicado: (2022)

Emerging Research on Endocrine Disruptors
por: Schwartz, David A., et al.
Publicado: (2007)

National strategy on endocrine disruptors.
Publicado: (1996)

Cannot write session to /tmp/vufind_sessions/sess_42ljrhahspeh6ubnegmm2oinoi